BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 10066659)

  • 1. Immunoglobulin subclass distribution and diagnostic value of Leishmania donovani antigen-specific immunoglobulin G3 in Indian kala-azar patients.
    Anam K; Afrin F; Banerjee D; Pramanik N; Guha SK; Goswami RP; Gupta PN; Saha SK; Ali N
    Clin Diagn Lab Immunol; 1999 Mar; 6(2):231-5. PubMed ID: 10066659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian kala-azar patients after chemotherapy.
    Anam K; Afrin F; Banerjee D; Pramanik N; Guha SK; Goswami RP; Saha SK; Ali N
    Infect Immun; 1999 Dec; 67(12):6663-9. PubMed ID: 10569788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.
    Saha S; Mazumdar T; Anam K; Ravindran R; Bairagi B; Saha B; Goswami R; Pramanik N; Guha SK; Kar S; Banerjee D; Ali N
    J Clin Microbiol; 2005 Mar; 43(3):1269-77. PubMed ID: 15750095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin G subclass-specific antileishmanial antibody responses in Indian kala-azar and post-kala-azar dermal leishmaniasis.
    Ghosh AK; Dasgupta S; Ghose AC
    Clin Diagn Lab Immunol; 1995 May; 2(3):291-6. PubMed ID: 7664174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patients.
    Elassad AM; Younis SA; Siddig M; Grayson J; Petersen E; Ghalib HW
    Clin Exp Immunol; 1994 Feb; 95(2):294-9. PubMed ID: 8306504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of serological markers to monitor the disease status of Indian post kala-azar dermal leishmaniasis.
    Mukhopadhyay D; Das NK; De Sarkar S; Manna A; Ganguly DN; Barbhuiya JN; Maitra AK; Hazra A; Chatterjee M
    Trans R Soc Trop Med Hyg; 2012 Nov; 106(11):668-76. PubMed ID: 22920931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of immunoglobulin G and its subclass response to Indian kala-azar infection before and after chemotherapy.
    Ravindran R; Anam K; Bairagi BC; Saha B; Pramanik N; Guha SK; Goswami RP; Banerjee D; Ali N
    Infect Immun; 2004 Feb; 72(2):863-70. PubMed ID: 14742530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of IgG subclasses in antimonial unresponsive Indian kala-azar patients.
    Chatterjee M; Basu K; Basu D; Bannerjee D; Pramanik N; Guha SK; Goswami RP; Saha SK; Mandal C
    Clin Exp Immunol; 1998 Dec; 114(3):408-13. PubMed ID: 9844051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen.
    Singh S; Kumari V; Singh N
    Clin Diagn Lab Immunol; 2002 May; 9(3):568-72. PubMed ID: 11986261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of anti-gal enzyme-linked immunosorbent assay for the diagnosis of Indian post-kala-azar dermal leishmaniasis.
    Datta S; Ghosh M; Sarkar S; Saha B; Mukhopadhyay S
    Indian J Dermatol Venereol Leprol; 2019; 85(6):578-589. PubMed ID: 31397399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis.
    Marlais T; Bhattacharyya T; Singh OP; Mertens P; Gilleman Q; Thunissen C; Hinckel BCB; Pearson C; Gardner BL; Airs S; de la Roche M; Hayes K; Hafezi H; Falconar AK; Eisa O; Saad A; Khanal B; Bhattarai NR; Rijal S; Boelaert M; El-Safi S; Sundar S; Miles MA
    Front Cell Infect Microbiol; 2018; 8():427. PubMed ID: 30619774
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of antileishmanial IgG antibodies and Leishmania-specific antigens in sera from Yemeni patients with visceral leishmaniasis.
    Azazy AA; Nasher ST; Ishaq A; Bin-Muhanna M; Chance ML
    Ann Trop Med Parasitol; 2003 Oct; 97(7):689-95. PubMed ID: 14613628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of an improved method for the recombinant k 39 enzyme-linked immunosorbent assay to detect visceral leishmaniasis disease and infection in Bangladesh.
    Kurkjian KM; Vaz LE; Haque R; Cetre-Sossah C; Akhter S; Roy S; Steurer F; Amann J; Ali M; Chowdhury R; Wagatsuma Y; Williamson J; Crawford S; Breiman RF; Maguire JH; Bern C; Secor WE
    Clin Diagn Lab Immunol; 2005 Dec; 12(12):1410-5. PubMed ID: 16339064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of specific antibody isotypes and subtypes before and after treatment of American visceral leishmaniasis.
    da Matta VL; Hoshino-Shimizu S; Dietze R; Corbett CE
    J Clin Lab Anal; 2000; 14(1):5-12. PubMed ID: 10645978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test.
    Bhattacharyya T; Ayandeh A; Falconar AK; Sundar S; El-Safi S; Gripenberg MA; Bowes DE; Thunissen C; Singh OP; Kumar R; Ahmed O; Eisa O; Saad A; Silva Pereira S; Boelaert M; Mertens P; Miles MA
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3273. PubMed ID: 25340782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significantly lower anti-Leishmania IgG responses in Sudanese versus Indian visceral leishmaniasis.
    Bhattacharyya T; Bowes DE; El-Safi S; Sundar S; Falconar AK; Singh OP; Kumar R; Ahmed O; Boelaert M; Miles MA
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2675. PubMed ID: 24587456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serodiagnostic and immunoprophylactic potential of a 78kDa protein of Leishmania donovani of Indian origin.
    Mukherjee M; Bhattacharyya A; Duttagupta S
    Med Sci Monit; 2002 Apr; 8(4):BR117-22. PubMed ID: 11951057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A diagnostic ELISA for visceral leishmaniasis, based on antigen from media conditioned by Leishmania donovani promastigotes.
    Martin SK; Thuita-Harun L; Adoyo-Adoyo M; Wasunna KM
    Ann Trop Med Parasitol; 1998 Jul; 92(5):571-7. PubMed ID: 9797830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of leishmania antigen in kala azar patients using monoclonal antibodies.
    Sinha R; Arora SK; Datta U; Sehgal S
    Microbiol Immunol; 1992; 36(4):391-400. PubMed ID: 1406366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoblotting identifies an antigen recognized by anti gp63 in the immune complexes of Indian kala-azar patient sera.
    Sanyal T; Ghosh DK; Sarkar D
    Mol Cell Biochem; 1994 Jan; 130(1):11-7. PubMed ID: 8190117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.